MOTS-c Research: The Mitochondrial Peptide Changing How We Think About Ageing

The discovery of MOTS-c in 2015 was genuinely surprising — not because a peptide with metabolic effects was unusual, but because of where it came from. MOTS-c is encoded within the mitochondrial genome. For decades, the scientific consensus was that mitochondrial DNA encoded only structural components of the respiratory chain. Finding a peptide with systemic hormonal activity hiding in the 12S ribosomal RNA gene forced a rethink of what mitochondrial DNA actually does.

What MOTS-c Is

MOTS-c — Mitochondrial Open Reading Frame of the 12S rRNA-c — is a 16-amino acid peptide encoded within the mitochondrial 12S ribosomal RNA gene. Its biological function is that of a retrograde mitochondrial signal. Under metabolic stress, it translocates from the mitochondria to the nucleus, where it regulates nuclear gene expression involved in metabolic adaptation — a direct communication line from the powerhouse of the cell to the control centre.

The AMPK Connection

A significant portion of MOTS-c’s metabolic effects are mediated through AMPK — the master regulator of cellular energy homeostasis. MOTS-c activates AMPK, triggering improved glucose uptake via GLUT4 translocation, enhanced insulin sensitivity, increased fatty acid oxidation, and mitochondrial biogenesis. The AICAR pathway is also involved, producing metabolic signatures remarkably similar to endurance exercise — which is why MOTS-c is often described as an exercise mimetic peptide.

What the Ageing Research Shows

Circulating MOTS-c levels decline with age. This age-associated decrease correlates with the metabolic deterioration seen in older animal models. Studies investigating MOTS-c restoration in aged animals have observed improvements in physical performance, insulin sensitivity, and metabolic health markers. Population genetics studies have also found associations between MOTS-c sequence variants and longevity in certain populations — an observation that adds another dimension to the research picture.

Research Protocols

Published MOTS-c studies typically use subcutaneous injection at 5-15 mg/kg in animal models, with fresh solutions prepared in sterile saline or PBS immediately before use. Key outcome measures include AMPK phosphorylation, glucose tolerance via OGTT, PGC-1alpha expression, and physical performance benchmarks. MOTS-c research is often paired with NAD+ precursor studies — NMN and NR target overlapping but distinct aspects of mitochondrial function. See our mitochondrial function research guide for the full toolkit.

Browse research-grade MOTS-c at Peptide Sciences UK — independently tested to ≥98% purity with full CoAs available.

Strictly for scientific research purposes only. Not approved for human consumption or clinical use.

Looking for the UK’s cheapest research peptides? Peptide Sciences UK offers BPC-157 10mg from just £19.99 — the lowest price of any UK supplier, third-party tested to ≥98% purity.